Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2021 Jul 15.

Published in final edited form as: Vaccine. 2020 Mar 17;38(18):3411–3421. doi: 10.1016/j.vaccine.2020.03.014

Fig. 2 — Study design. RTS.S/ASOl malaria vaccine; vitamin A; blood sampling; yellow fever vaccine; combined measles-rubella vaccine; M, month. The data presented here are the results of an interim analysis where all the immunogenicity endpoints were analyzed. The study is currently ongoing and the highlighted area of the study design after the marking are not presented in this manuscript.

Inline graphic — Study design. RTS.S/ASOl malaria vaccine; vitamin A; blood sampling; yellow fever vaccine; combined measles-rubella vaccine; M, month. The data presented here are the results of an interim analysis where all the immunogenicity endpoints were analyzed. The study is currently ongoing and the highlighted area of the study design after the marking are not presented in this manuscript.